James O. Wilson

Array ( [id] => 2598800 [patent_doc_number] => 04965350 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-10-23 [patent_title] => 'Pyridopyrimidine nucleotide compounds' [patent_app_type] => 1 [patent_app_number] => 7/351317 [patent_app_country] => US [patent_app_date] => 1989-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 7051 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/965/04965350.pdf [firstpage_image] =>[orig_patent_app_number] => 351317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2785482 [patent_doc_number] => 05093324 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-03-03 [patent_title] => 'Thiadiazole antiviral agents' [patent_app_type] => 1 [patent_app_number] => 7/339033 [patent_app_country] => US [patent_app_date] => 1989-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4954 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/093/05093324.pdf [firstpage_image] =>[orig_patent_app_number] => 339033 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1586011 [patent_doc_number] => 06358934 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-19 [patent_title] => 'Anti-retroviral activity of 2,3-dideoxy-3-fluoronucleosides' [patent_app_type] => B1 [patent_app_number] => 07/319840 [patent_app_country] => US [patent_app_date] => 1989-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2105 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/358/06358934.pdf [firstpage_image] =>[orig_patent_app_number] => 07319840 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3117685 [patent_doc_number] => 05449769 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-09-12 [patent_title] => 'Method and reagent for sulfurization of organophosphorous compounds' [patent_app_type] => 1 [patent_app_number] => 7/319570 [patent_app_country] => US [patent_app_date] => 1989-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 4034 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/449/05449769.pdf [firstpage_image] =>[orig_patent_app_number] => 319570 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2705524 [patent_doc_number] => 04992426 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-02-12 [patent_title] => 'Antiparasitic 5\'-sulfamoyl nucleosides' [patent_app_type] => 1 [patent_app_number] => 7/316421 [patent_app_country] => US [patent_app_date] => 1989-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5359 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/992/04992426.pdf [firstpage_image] =>[orig_patent_app_number] => 316421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2620359 [patent_doc_number] => 04968788 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-11-06 [patent_title] => 'Biologically reversible phosphate and phosphonate protective gruops' [patent_app_type] => 1 [patent_app_number] => 7/300264 [patent_app_country] => US [patent_app_date] => 1989-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 5999 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/968/04968788.pdf [firstpage_image] =>[orig_patent_app_number] => 300264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2782144 [patent_doc_number] => 05087618 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-02-11 [patent_title] => 'Redox carriers for brain-specific drug delivery' [patent_app_type] => 1 [patent_app_number] => 7/295663 [patent_app_country] => US [patent_app_date] => 1989-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 0 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 338 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/087/05087618.pdf [firstpage_image] =>[orig_patent_app_number] => 295663 [rel_patent_id] =>[rel_patent_doc_number] =>)